Clinical Trials Directory

Trials / Completed

CompletedNCT04279080

LARS in Ovarian Cancer Patients

Low Anterior Resection Syndrome (LARS) in Ovarian Cancer Patients - a Multi-centre Comparative Analysis.

Status
Completed
Phase
Study type
Observational
Enrollment
125 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

Background: Low anterior resection syndrome (LARS) is a common functional disorder after low anterior resection impacting quality of life. Data on LARS derives nearly exclusively from rectal cancer studies. Therefore, the study was designed to assess LARS in advanced epithelial ovarian cancer (EOC) patients, who underwent rectal resection and to compare it with a female rectal cancer cohort. Methods: A cross-sectional multi-centre analysis was performed for female patients suffering from either rectal or EOC who received a low anterior resection as part of their therapy regimen. None of the patients received pre- or postoperative radiotherapy. LARS was defined by using the validated LARS score and its severity was divided into "no", "minor" and "major LARS".

Conditions

Interventions

TypeNameDescription
OTHERlow anterior resection syndrome evaluationevaluation of postoperative functional bowel outcome

Timeline

Start date
2003-01-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2020-02-20
Last updated
2020-02-20

Source: ClinicalTrials.gov record NCT04279080. Inclusion in this directory is not an endorsement.